Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New insights into p53 function from structural studies

C H Arrowsmith1, P Morin

  • 1Division of Molecular and Structural Biology, Ontario Cancer Institute, University of Toronto, Canada.

Oncogene
|April 4, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integration and electrical evaluation of WS<sub>2</sub> and MoS<sub>2</sub> fets in a 300 mm pilot line.

Discover electronics·2026
Same author

Stroke Triage Alpha Rescue Score (STARS): Prehospital phone-based tool to identify cerebral large vessel occlusion.

Revue neurologique·2025
Same author

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer.

Nature communications·2018
Same author

Bifunctional mannoside-glucosinolate glycoconjugates as enzymatically triggered isothiocyanates and FimH ligands.

Organic & biomolecular chemistry·2018
Same author

Characterization of miRNAs modulated by torpor in the hibernating ground squirrel Ictidomys tridecemlineatus liver by next-generation sequencing.

Cryo letters·2018
Same author

[Professional practice evaluation of injectable drug preparation and administration in neonatology].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2017
Same journal

Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Oncogene·2026
Same journal

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C-mutant non-small cell lung cancer.

Oncogene·2026
Same journal

Histone lactylation-driven IGF2BP3 promotes intrahepatic cholangiocarcinoma progression via SPP1/CD44-dependent macrophage polarization.

Oncogene·2026
Same journal

Correction: SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.

Oncogene·2026
Same journal

Correction: Liver-specific SIRT1 knockout-induced hyperglycemia promotes spontaneous lung adenocarcinomas through HSF1-MDM2.

Oncogene·2026
Same journal

Correction: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.

Oncogene·2026
See all related articles

Structural studies of p53 protein reveal key chemical groups for stability and function. Future research on full-length p53 will clarify its conformational transitions for therapeutic development.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Molecular Biology

Background:

  • Recent structural analyses of p53 protein have significantly advanced understanding of its biochemical activities.
  • Detailed insights into chemical groups involved in p53 stability, conformation, and functional interactions are now available.

Purpose of the Study:

  • To leverage current p53 structural data for designing novel therapeutics, such as restoring DNA-binding competence in mutants.
  • To guide the development of targeted therapies by understanding the p53 tetramerization domain structure.
  • To identify the conformational transition between latent and active p53 states and explore modulation strategies.

Main Methods:

  • Structural analysis of p53 protein domains.
  • Biochemical characterization of protein stability and functional interactions.

Related Experiment Videos

  • Computational modeling for therapeutic design.

    • Main Results:

    • Provided detailed structural information on p53, highlighting critical chemical groups for its stability and function.
    • Established a structural basis for designing therapeutics to correct DNA-binding mutations in p53.
    • Identified the tetramerization domain structure as a target for developing specific p53-based therapies.

    Conclusions:

    • Current p53 structures are foundational for developing targeted therapeutics.
    • Further structural studies of full-length p53 are crucial for a complete understanding of its function.
    • Elucidating p53 conformational transitions is key for future therapeutic interventions.